16 results on '"Julia Burd"'
Search Results
2. Preterm Birth and Sex
- Author
-
Julia Burd and Vincenzo Berghella
- Published
- 2022
3. How long is too long? Assessing risks of prolonged latent phase of labor
- Author
-
Julia Burd, Candice Woolfolk, Michael Dombrowski, Ebony B. Carter, Jeannie C. Kelly, Antonina I. Frolova, Anthony O. Odibo, Alison G. Cahill, and Nandini Raghuraman
- Subjects
Obstetrics and Gynecology - Published
- 2023
4. Interpregnancy interval in multiparas: does it impact the labor curve?
- Author
-
Julia Burd, Candice Woolfolk, Antonina I. Frolova, Amanda C. Zofkie, Anthony O. Odibo, Ebony B. Carter, Jeannie C. Kelly, Alison G. Cahill, and Nandini Raghuraman
- Subjects
Obstetrics and Gynecology - Published
- 2023
5. Evaluation of an Initiative to Decrease the Use of Oxygen Supplementation for Category II Fetal Heart Rate Tracings
- Author
-
Vincenzo Berghella, Daniel G. Duncan, Julia Burd, Kathryn Anderson, Johanna Quist-Nelson, and Jason K. Baxter
- Subjects
medicine.medical_specialty ,Fetus ,Oxygen supplementation ,Obstetrics ,business.industry ,Obstetrics and Gynecology ,Guideline ,Hypoxemia ,Fetal heart rate ,Statistical significance ,medicine ,Gestation ,medicine.symptom ,business ,Oxygen saturation (medicine) - Abstract
OBJECTIVE To examine compliance with a guideline to reduce exposure to supplemental oxygen for category II fetal heart rate (FHR) tracings in normally oxygenated laboring patients. METHODS All patients in labor in an urban academic medical center from January 1 to July 31, 2020 were assessed. The preintervention group included those who delivered from January 1 to March 19, 2020. On March 20, 2020, a new guideline took effect that recommended no maternal supplemental oxygen for category II FHR tracings. The postintervention group delivered from March 20 to July 31, 2020. Exclusion criteria were planned cesarean delivery, multiple gestations, delivery at less than 24 weeks of gestation, intrauterine fetal death, and patients who received supplemental oxygen for an oxygen saturation lower than 95%. The primary outcome was the percentage of patients who received oxygen in labor analyzed by control charts and the rules of special cause variation. Chi-squared and t tests were used for secondary outcome assessment. P
- Published
- 2021
6. Blood type and postpartum hemorrhage by mode of delivery: A retrospective cohort study
- Author
-
Vincenzo Berghella, Julia Burd, J. Biba Nijjar, Sara Edwards, Anju Suhag, and Johanna Quist-Nelson
- Subjects
medicine.medical_specialty ,Blood transfusion ,medicine.medical_treatment ,law.invention ,03 medical and health sciences ,Dilation and curettage ,0302 clinical medicine ,Pregnancy ,law ,ABO blood group system ,Humans ,Medicine ,030212 general & internal medicine ,reproductive and urinary physiology ,Retrospective Studies ,Blood type ,Labor, Obstetric ,030219 obstetrics & reproductive medicine ,Hysterectomy ,Cesarean Section ,business.industry ,Vaginal delivery ,Obstetrics ,Postpartum Hemorrhage ,Obstetrics and Gynecology ,Retrospective cohort study ,Delivery, Obstetric ,Intensive care unit ,Reproductive Medicine ,Female ,business - Abstract
Objective To assess the relationship between postpartum hemorrhage and ABO blood type for vaginal delivery and cesarean delivery. Study design This is a retrospective cohort study of data abstracted from the PeriBank database regarding demographics and delivery outcomes. All live singleton deliveries from January 2011 until March 2018 were included in this study. Exclusion criteria were sickle cell disease and multiple gestations. Analyses were conducted separately for cesarean delivery and vaginal delivery. Quantitative variables were analyzed with analysis of variance testing and categorical variables with chi square testing. Significant demographic differences between groups were controlled for using multivariate logistical regression. The primary outcome was the rate of postpartum hemorrhage by blood type (A, B, AB, and O), defined as blood loss >500 mL in vaginal delivery and >1000 mL in cesarean delivery. 43,437 patients were screened and 32,023 women met inclusion criteria (22,484 vaginal deliveries (70.2%) and 9539 cesarean deliveries (29.8%)). Results In the vaginal delivery group there were differences in age, parity, race, use of regional anesthesia, rate of induction of labor, and thrombocytopenia between blood types. In the cesarean delivery group, age, parity, and race were significantly different between blood types. There was no observed difference in the rate of postpartum hemorrhage by blood type for those who delivered via vaginal delivery when controlling for demographic differences (p = 0.2). In the cesarean delivery group, there was a significantly higher rate of postpartum hemorrhage in women with type O blood (5.2% type O vs 3.8% type A vs 4.4% type B vs 4.2% type AB, p = 0.035), including when controlling for demographic differences (p = 0.02). In both vaginal and cesarean delivery groups, there was no difference in rates of any of the secondary outcomes, including blood transfusion, hysterectomy, intrapartum dilation and curettage, and intensive care unit admission. Conclusion Although this study found no statistically significant difference in clinical outcomes between blood types, type O blood may be an additional risk factor to consider for postpartum hemorrhage at the time of cesarean delivery.
- Published
- 2021
7. Physiologic Changes
- Author
-
Jason Baxter and Julia Burd
- Published
- 2022
8. Manual rotation of occiput posterior or occiput transverse position: a systematic review and meta-analysis
- Author
-
Julia Burd, Julie Gomez, Vincenzo Berghella, Federica Bellussi, Bradley de Vries, Hala Phipps, Julie Blanc, Jeffrey Broberg, Aaron B. Caughey, Caroline Verhaeghe, and Johanna Quist-Nelson
- Subjects
Obstetrics and Gynecology - Published
- 2022
9. Criteria for maternal screening echocardiograms: a single center pilot study
- Author
-
Julia Burd, Johanna Quist-Nelson, Julie Gomez, Sarah Abelman, Lauren Suggs, and Rebekah McCurdy
- Subjects
Obstetrics and Gynecology - Published
- 2022
10. Implementation of Guideline for Transthoracic Echocardiography Screening for Pregnant Women With Risk for Cardiac Disease [A221]
- Author
-
Sarah Abelman, Julia Burd, Molly Muir, Jessica M. Smith, and Rebekah J. McCurdy
- Subjects
Obstetrics and Gynecology - Published
- 2022
11. Prophylactic rotation for malposition in the second stage of labor: a systematic review and meta-analysis of randomized controlled trials
- Author
-
Julia Burd, Julie Gomez, Vincenzo Berghella, Federica Bellussi, Bradley de Vries, Hala Phipps, Julie Blanc, Jeffrey Broberg, Aaron B. Caughey, Caroline Verhaeghe, and Johanna Quist-Nelson
- Subjects
Fetus ,Labor Stage, Second ,Pregnancy ,1114 Paediatrics and Reproductive Medicine ,Humans ,Female ,General Medicine ,Obstetrics & Reproductive Medicine ,Ultrasonography, Prenatal ,Labor Presentation ,Randomized Controlled Trials as Topic - Abstract
OBJECTIVE: This study aimed to evaluate if manual rotation, undertaken during labor, of fetuses in occiput posterior or occiput transverse position led to an increased rate of spontaneous vaginal delivery. DATA SOURCES: Searches were performed in MEDLINE, Ovid, Scopus, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials with the use of a combination of keywords and text words related to "occiput posterior," "occiput transverse," and "manual rotation" from inception of the databases to July 2021. STUDY ELIGIBILITY CRITERIA: We included all randomized controlled trials evaluating manual rotation of fetuses in the occiput posterior or occiput transverse position during labor. METHODS: The primary outcome was the rate of spontaneous vaginal delivery. Meta-analyses were performed using the random effects model of DerSimonian and Laird to determine the relative risks or mean differences with 95% confidence intervals. RESULTS: A total of 643 records were screened with inclusion of 6 articles and 1002 randomized patients. All included studies compared manual rotation of fetuses in occiput posterior or occiput transverse position, all confirmed using ultrasound examinations, after complete cervical dilation with either no rotation or a sham rotation procedure. There was no difference in the rate of spontaneous vaginal delivery with manual rotation (relative risk, 1.07; 95% confidence interval, 0.95-1.20) nor was there any difference in any other maternal or fetal outcomes. In a subgroup analysis of occiput posterior fetuses, there was a 12.80-minute decrease in the length of the second stage of labor in the manual rotation group (mean difference, -12.80; 95% confidence interval, -22.61 to -2.99). There were no significant differences in any other maternal or fetal outcomes in the occiput posterior subgroup and no differences in the occiput transverse subgroup. CONCLUSION: Prophylactic manual rotation of fetuses in occiput posterior or occiput transverse position, confirmed using ultrasound examination, did not increase the rate of spontaneous vaginal delivery compared with no manual rotation. Manual rotation of the occiput posterior fetal head early during the second stage of labor was associated with a significant 12.8-minute decrease in the length of the second stage of labor with no changes in any other maternal or fetal outcomes. There were no differences demonstrated for fetuses rotated from occiput transverse position or for the combination of occiput posterior and occiput transverse fetuses. Because there is some evidence of benefit, prophylactic manual rotation can be offered to patients during the second stage of labor presenting with occiput posterior position of the fetal head documented during ultrasound examination.
- Published
- 2022
12. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study
- Author
-
Hannah Anastasio, Laura Felder, Kathryn Anderson, Adina R. Kern-Goldberger, Anju Suhag, Julia Burd, Reshama Navathe, Rebecca Pierce-Williams, Angela Bianco, Karina Avila, William T. Schnettler, Christina A. Penfield, Peter S. Bernstein, Devon S. O’Brien, Rasha Khoury, Adi Hirshberg, Harish M. Sedev, Jenani S. Jayakumaran, Vincenzo Berghella, Joanne Stone, Chelsea DeBolt, Ashley S. Roman, Justin S. Brandt, Sindhu K. Srinivas, Shabani Ahluwalia, Meredith L. Birsner, Cara D. Dolin, and Adeeb Khalifeh
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,Critical Illness ,Cardiomyopathy ,coronavirus ,Severity of Illness Index ,Article ,Cohort Studies ,Pregnancy ,Fraction of inspired oxygen ,medicine ,Humans ,Pregnancy Complications, Infectious ,business.industry ,Cesarean Section ,SARS-CoV-2 ,Infant, Newborn ,Pregnancy Outcome ,Gestational age ,COVID-19 ,General Medicine ,medicine.disease ,Infectious Disease Transmission, Vertical ,United States ,Hospitalization ,Maternal Mortality ,Respiratory failure ,Cohort ,Premature Birth ,Maternal death ,Female ,SARs-CoV2 ,business ,Cohort study - Abstract
Background The coronavirus disease 2019 pandemic has had an impact on healthcare systems around the world with 3 million people contracting the disease and 208,000 cases resulting in death as of this writing. Information regarding coronavirus infection in pregnancy is still limited. Objective This study aimed to describe the clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnant women with positive laboratory testing for severe acute respiratory syndrome coronavirus 2. Study Design This is a cohort study of pregnant women with severe or critical coronavirus disease 2019 hospitalized at 12 US institutions between March 5, 2020, and April 20, 2020. Severe disease was defined according to published criteria as patient-reported dyspnea, respiratory rate >30 per minute, blood oxygen saturation ≤93% on room air, ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen 50% within 24–48 hours on chest imaging. Critical disease was defined as respiratory failure, septic shock, or multiple organ dysfunction or failure. Women were excluded from the study if they had presumed coronavirus disease 2019, but laboratory testing was negative. The primary outcome was median duration from hospital admission to discharge. Secondary outcomes included need for supplemental oxygen, intubation, cardiomyopathy, cardiac arrest, death, and timing of delivery. The clinical courses are described by the median disease day on which these outcomes occurred after the onset of symptoms. Treatment and neonatal outcomes are also reported. Results Of 64 hospitalized pregnant women with coronavirus disease 2019, 44 (69%) had severe disease, and 20 (31%) had critical disease. The following preexisting comorbidities were observed: 25% had a pulmonary condition, 17% had cardiac disease, and the mean body mass index was 34 kg/m2. Gestational age was at a mean of 29±6 weeks at symptom onset and a mean of 30±6 weeks at hospital admission, with a median disease day 7 since first symptoms. Most women (81%) were treated with hydroxychloroquine; 7% of women with severe disease and 65% of women with critical disease received remdesivir. All women with critical disease received either prophylactic or therapeutic anticoagulation during their admission. The median duration of hospital stay was 6 days (6 days [severe group] and 10.5 days [critical group]; P=.01). Intubation was usually performed around day 9 on patients who required it, and peak respiratory support for women with severe disease was performed on day 8. In women with critical disease, prone positioning was required in 20% of cases, the rate of acute respiratory distress syndrome was 70%, and reintubation was necessary in 20%. There was 1 case of maternal cardiac arrest, but there were no cases of cardiomyopathy or maternal death. Thirty-two of 64 (50%) women with coronavirus disease 2019 in this cohort delivered during their hospitalization (34% [severe group] and 85% [critical group]). Furthermore, 15 of 17 (88%) pregnant women with critical coronavirus disease 2019 delivered preterm during their disease course, with 16 of 17 (94%) pregnant women giving birth through cesarean delivery; overall, 15 of 20 (75%) women with critical disease delivered preterm. There were no stillbirths or neonatal deaths or cases of vertical transmission. Conclusion In pregnant women with severe or critical coronavirus disease 2019, admission into the hospital typically occurred about 7 days after symptom onset, and the duration of hospitalization was 6 days (6 [severe group] vs 12 [critical group]). Women with critical disease had a high rate of acute respiratory distress syndrome, and there was 1 case of cardiac arrest, but there were no cases of cardiomyopathy or maternal mortality. Hospitalization of pregnant women with severe or critical coronavirus disease 2019 resulted in delivery during the clinical course of the disease in 50% of this cohort, usually in the third trimester. There were no perinatal deaths in this cohort.
- Published
- 2020
13. Effect of intrapartum oxygen on the rate of cesarean delivery: a meta-analysis
- Author
-
Johanna Quist-Nelson, Hany Aly, Suzanne Moors, Julia Burd, Nandini Raghuraman, and Vincenzo Berghella
- Subjects
Fetus ,medicine.medical_specialty ,Labor, Obstetric ,Cesarean Section ,Obstetrics ,business.industry ,Infant, Newborn ,MEDLINE ,General Medicine ,Heart Rate, Fetal ,Delivery, Obstetric ,Confidence interval ,law.invention ,Oxygen ,Randomized controlled trial ,Pregnancy ,law ,Meta-analysis ,Relative risk ,Room air distribution ,medicine ,Humans ,Female ,Cesarean delivery ,business - Abstract
This study aimed to determine if maternal intrapartum administration of oxygen altered the rate of cesarean delivery compared with room air.This study was a systematic review and meta-analysis of randomized controlled trials. Searches were performed in MEDLINE, OVID, Scopus, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials using a combination of key words related to "pregnant patients," "labor," "oxygen," "fetus," "newborn," and pregnancy outcomes from database inception until April 2020. The study was registered in PROSPERO (registration number CRD42020162110).The inclusion criteria were randomized controlled trials of maternal administration of oxygen compared with room air in labor. The exclusion criteria were quasi-randomized trials and oxygen administered for planned cesarean deliveries. The primary outcome was the rate of cesarean delivery. Secondary maternal and neonatal outcomes, including cord gas values, were analyzed.The Cochrane Handbook guidelines were used to assess bias in trials. To calculate the relative risk or mean differences with confidence intervals, a random-effects model was employed. Subgroup analyses were performed for women who received oxygen for nonreassuring fetal heart rate monitoring or prophylactically.Five randomized controlled trials, including 768 women, were included in the meta-analysis, 3 using prophylactic oxygen and 2 using oxygen for nonreassuring fetal heart rate monitoring. The risk of bias was generally considered low. There was no statistically significant difference in the rate of cesarean delivery between patients administered oxygen and patients provided room air (16 of 365 [4.4%] vs 11 of 379 [2.9%]; risk ratio 1.5; 95% confidence interval, 0.7-3.3). In addition, there were no statistically significant differencs in the rates of cesarean delivery for nonreassuring fetal heart rate monitoring, operative vaginal deliveries, Apgar scores of7, neonatal intensive care unit admissions, or cord blood gas values. There were no statistically significant difference when analyzing oxygen for nonreassuring fetal heart rate monitoring alone or prophylactic oxygen alone. Data regarding FHT is mixed, with one study suggesting an improvement and three suggesting no change.Maternal intrapartum oxygen administration was not associated with any differences in the rate of cesarean delivery or any secondary outcomes compared with room air overall and in the subgroups of therapeutic (for nonreassuring fetal heart rate monitoring) or prophylactic administration in this meta-analysis. Large randomized controlled trials are necessary to further examine any possible benefits or harms of oxygen administration in labor, particularly for nonreassuring fetal heart rate monitoring.
- Published
- 2021
14. 139 Cessation of hyperoxygenation for category II fetal heart tracings: a quality improvement study
- Author
-
Vincenzo Berghella, Daniel Duncan, Julia Burd, Johanna Quist-Nelson, Jason K. Baxter, and Kathryn Anderson
- Subjects
medicine.medical_specialty ,Poster Session I ,Quality management ,Text mining ,Thursday, January 28, 2021 • 1:30 PM - 2:30 PM ,business.industry ,Internal medicine ,medicine ,Cardiology ,Obstetrics and Gynecology ,Fetal heart ,business - Published
- 2021
15. Decreased incidence of preterm birth during coronavirus disease 2019 pandemic
- Author
-
Julia Burd, Vincenzo Berghella, Rupsa C. Boelig, Amanda Roman, and Kathryn Anderson
- Subjects
Pediatrics ,medicine.medical_specialty ,Pregnancy ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Incidence (epidemiology) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,Gestational age ,General Medicine ,medicine.disease ,Pandemic ,medicine ,business - Published
- 2020
16. 649: ABO blood type and postpartum hemorrhage by mode of delivery: a retrospective cohort study
- Author
-
Anju Suhag, Julia Burd, Vincenzo Berghella, Johanna Quist-Nelson, Sara Edwards, and Biba Nijjar
- Subjects
medicine.medical_specialty ,Mode of delivery ,business.industry ,Obstetrics ,ABO blood group system ,Obstetrics and Gynecology ,Medicine ,Retrospective cohort study ,business - Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.